Our management team represents over 150 years of plasma experience
The management team represents over nearly 150 years collective
experience in the blood, plasma, and biopharma industries.
Jerome Parnell, III
CEO & President
Jerome has been in the Blood and Plasma Industry for 20 years (1999). His Industry Related Work Experience includes: International Bio-Resources, LLC (IBR), Baxter International, Alpha Therapeutic Corporation. Jerome has managed and organized the structural development of a growth oriented Bio-tech company with 48 locations and 1700 employees. He specializes in Operations and Production Management, Strategic Management, Organizational Development, Project Management, and New Business Development.
Greg is a Certified Public Accountant with over 26 years experience in accounting and corporate finance. Greg has served in a CFO capacity for over 20 years. His core talents include: Cash Management, Forecasting, Finance, Human Resources, and IT management. As a founding member of a previous plasma collection company, also a startup, he was responsible for the Accounting, Human Resources and IT. He has twice before taken a company from an idea, to a business plan, to funding, to a viable operating entity, including a previous plasma company startup which was sold in 2010. Greg has been involved with the Source Plasma industry since 2002.
Scott has been in the blood and plasma industry for 31 years (1988). His industry experience includes the following companies: International BioResources, Serologicals, Stough Enterprises, SeraMed, Seramune, and Acadiana Ventures. Scott managed the opening and FDA licensing of 48 US plasma centers over a 3-year period. He engaged the FDA in 48 US plasma center pre- licensed inspections resulting in all centers receiving biologic license and developed a corporate support structure to oversee the operations. His skill set includes: Plasma Operations Subject Matter Expert (SME), training, mentoring, and staff development. Operating system designer, developer, operating efficiencies and sustainability.
Charles Richard, Jr, MPH
Charles has been in the health care industry for more than 30 years. He began in the Plasma industry in 2000 with Sera-Tec Biologicals and has held positions of increased scope and responsibility with Biolife Plasma Services, Talecris Plasma Services, International BioResources (IBR), and Octapharma Plasma Inc. While with IBR, Charles successfully opened eight new plasma centers which were FDA, PPTA and European certified. More recently he was a Divisional Director with Octapharma Plasma Inc., with operational and quality oversight of 23 plasma centers across the United States. He holds a Master’s in Public Health from the University of North Carolina at Chapel Hill.
VP, New Center Development
Kathryn has 13 years of plasma industry experience. She worked for International BioResources managing the team that opened 48 centers in three years. Industry experience includes managing and developing: New Center Development (NCD) Corporate and Field teams, NCD Opening Matrix & Project Plans, Purchasing Department and Vendor Relationships, Human Resources Department, IT Department and Production Systems Department. She has also served as Director of Support Engineering and Energy Services at Global Data Systems where she managed the 24/7 Network Operations Center and Engineering Team which supported over 300 customer contracts. Kathryn specializes in Project Management, Process Development/Improvement, Resource Management, and Operational/Financial Reporting.
VP, Quality Assurance
Jeff has over 35 years of plasma industry experience with Desert Plasma, Alpha Therapeutic, Nations Biologics, SeraMed, Aventis, International BioResources, LLC, Talecris, and Octapharma Plasma Inc. Jeff has managed field operations, field quality, regulatory affairs, project teams, and audit groups. His successes include new center opening and licensure, center acquisition and integration, and FDA and European inspection preparation and certification. He is able to use his experience across multiple facets of the plasma industry to add support and expertise to a variety of donor center, corporate, and customer initiatives.
VP, Regulatory Affairs
Mike has over 30 years of plasma industry experience with: International BioResources, LLC, Serologicals, SeraCare, SeraMed, and Acadiana Ventures. Mike has been an FDA Authorized Official since 2002. Mike has a comprehensive background in all operational, quality and regulatory aspects of a plasma center from line staff, center manager to corporate quality and regulatory. He specializes in FDA regulatory submissions, SOP writing, Regulatory Affairs, Quality Assurance, Process Improvement, and cGMP.
& Employee Development
the global leader in plasma supply
ImmunoTek is strategically positioned to partner with pharmaceutical entities to open, manage, and operate plasma donor centers as a service, but is also structured to maintain long-term operations and center ownership.
history of success
- International BioResources, LLC (IBR) Developed, Opened, Licensed, and Operated 13 plasma centers.
- An additional 23 centers were purchased in June 2003 and operated through 2006.
- All 36 centers were sold along with 25 additional centers in various stages of development.
- IBR managed 39 FDA Inspections and 31 EU Inspections
- IBR managed approximately 3 million procedures
- IBR Developed, Opened, Licensed, and Operated 48 plasma centers.
- All 48 were sold on or before June 30, 2010.
- IBR developed advanced Standard Operating Procedures (“SOPs”), Training Manuals and New Center Development Plans.
- Contract Plasma Supply
- New Plasma Center Development
ImmunoTek and its subsidiaries manage plasma supply contracts and plasma center development agreements for various pharmaceutical companies:
Bayer Pharmaceuticals, Grifols BioTherapeutics S.A., Talecris BioPharma, Octapharma AG, Kedrion BioPharma, LFB Pharmaceuticals, Cangene BioPharma and Emergent Bio Solutions.
- The former COO, CFO, and VP, Operations of IBR formed a new company called ImmunoTek Bio Centers, LLC and acquired the total assets of IBR in November 2012.
- Assets included all intellectual property: Standard Operating Procedures (“SOPs”), Training Manuals and New Center Development Plans.
2014 – present
- ImmunoTek opened first center in March 2014.
- Since March, ImmunoTek has:
- Opened 35 centers
- Acquired 21 FDA Licenses
- Acquired 22 EU certificates
- Acquired numerous compliance licenses/certifications/approvals from customer audits and several regulatory agencies such as CLIA, PPTA, COLA, and AHCA.